Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
about
Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.Use of natalizumab in multiple sclerosis: current perspectives.Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children.Natalizumab in relapsing-remitting multiple sclerosis.Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.
P2860
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Safety and efficacy of nataliz ...... lizumab observational program.
@en
Safety and efficacy of nataliz ...... lizumab observational program.
@nl
type
label
Safety and efficacy of nataliz ...... lizumab observational program.
@en
Safety and efficacy of nataliz ...... lizumab observational program.
@nl
prefLabel
Safety and efficacy of nataliz ...... lizumab observational program.
@en
Safety and efficacy of nataliz ...... lizumab observational program.
@nl
P2093
P2860
P50
P1476
Safety and efficacy of nataliz ...... alizumab observational program
@en
P2093
Alain Maertens de Noordhout
Andreas Lysandropoulos
Annick Melin
Anoek Symons
Bart Van Wijmeersch
Bénédicte Dubois
Christian Sindic
Christiana Willems
Cécile Retif
Daniel Guillaume
P2860
P2888
P304
P356
10.1007/S13760-014-0308-9
P577
2014-06-11T00:00:00Z